MKRN3 is frequently mutated in non–small-cell lung cancers (NSCLCs), and genomic aberrations of MKRN3 are found to be enriched in NSCLC samples harboring KRAS mutations (Li et al., 2021). This evidence concerns the gene MKRN3 and non-small cell lung carcinoma.